I just want to say at the outset that, Mr. Davies, I commend you for your advocacy and for attacking the premise that if this is a legitimate drug, if this is legislation that is purposeful and is good for society—and you firmly believe that, and I respect that—then the heavy-handedness that we're seeing from the government is really hard to understand.
We've had some discussion with some of the officials about how we deal with other countries. I would argue that the most important part of that motion is that this is big; this is going to change us fundamentally as a society. There are groups out there—I'm talking about moms and dads with kids in school, about surgeons and physicians—who have some serious, serious concerns, but there also are groups outside of our jurisdiction. We mention Uruguay as a nation that's often held as an example of a jurisdiction that has adopted these.... From the research that I've done, it's very slim, at best, to suggest that this is at all like what we're proposing in this country. The Netherlands, where my parents come from and which had a very relaxed set of laws, is going back to another position.
I want to ask the officials. Do you feel that we've done enough? Again, in light of the fact that this legislation will be passed and will be enacted in July 2018, have we done enough? Have we searched and have we communicated to other jurisdictions? Have we looked at other jurisdictions? Really, this is cutting edge, but in light of the importance of this legislation, have we really done enough to make an educated decision on this legislation?
I invite anybody to respond.
Mr. Costen.